Figure 4. HR1 and HR2 antagonists block MDSC-mediated Nb clearance.
(A and B) Eggs/gm feces in Nb-infected ± MDSCs (M) on indicated days (D) and ± daily CT treatment (A) or every other day CIM treatment (B). (C) Day 14 analysis of total MDSCs. (D) Flow cytometric determination of liver monocytic or granulocytic populations. *P < 0.05; **P < 0.005; ***P < 0.0005. Mean ± sd; n ≥ 5 with two independent experiments.